Spector, Roseman, Kodroff, & Willis

SRKW complimented by judge in the Parmalat case
In the Parmalat litigation the court noted that SRKW and its co-counsel "did a wonderful job here for the class and were in all respects totally professional and totally prepared. I wish I had counsel this good in front of me in every case."

Judge compliments SRKW in approving landmark settlement
In approving the landmark $120 million settlement of the In Re OSB Antitrust Litigation, Judge Diamond of the federal court in Philadelphia stated: "Counsel have represented their clients with consummate skill and efficiency, bringing this massive matter to conclusion in less than three years. Lead class counsel – Jeffrey Corrigan and the other lawyers from Spector Roseman Kodroff & Willis – performed brilliantly in this exceptionally difficult case."
(more . . .)

SRKW negotiates $145 million first-of-its-kind trans-Atlantic securities settlement
SRKW negotiated a $145 million recovery on behalf of a global class of investors in the Converium/Scor action. In an unprecedented move, the case was settled on two continents, in New York and Amsterdam — the first such trans-Atlantic resolution to a securities class action.
(more . . .)

U.S. Parmalat class action reaches $90 million in settlements
SRKW has been among three firms leading the Parmalat action (Europe’s Enron), where we have obtained settlements thus far valued at $90 million, as well as innovative governance reforms.
(more . . .)

SRKW nominated as Class Action Law Firm of the Year
SRKW was nominated in 2007 and 2008 for the prestigious Class Action Law Firm of the Year award by Global Pensions magazine. Nominees are selected by pension funds around the world.

Northern Ireland Local Governmental Officers' Superannuation Committee appointed co-lead plaintiff in Lehman Brothers securities class action
SRKW's client, the Northern Ireland Local Governmental Officers' Superannuation Committee (NILGOSC), was recently appointed as a co-lead plaintiff in the Lehman Brothers Holdings securities class action pending in the Southern District of New York. Partner Robert Roseman noted that NILGOSC’s role "shows that European institutional investors, in the appropriate case, are taking an active role in US class actions when they have no other legal recourse in their own country."
(more . . .)

SRKW client part of historic pan-European Royal Dutch Shell settlement
SRKW represented a large European investor in the pan-European settlement of the Royal Dutch Shell action in the Netherlands, where European investors will share in the distribution of $450 million.
(more . . .)

SRKW seeks to protect European investors in Europe in three matters
SRKW is currently working with distinguished law firms in Europe to protect the rights of European investors who purchased shares of European Aeronautic Defence & Space Co. (EADS), UBS AG, and Société Générale SA.

SRKW files derivative action in California court on behalf of Genentech, Inc.
SRKW is seeking to maximize shareholder value by instituting a shareholder derivative suit on behalf of Genentech. This suit alleges that when Roche Holding AG, which owns approximately 56% of Genentech, sought to acquire the remaining shares, it did so at an unfair price — in breach of the fiduciary duties it and Genentech’s directors owed to the company’s shareholders.

SRKW settles Chicago Bridge action for $10.5 million plus governance reforms
SRKW acted as co-lead counsel in the Chicago Bridge securities fraud action, recovering $10.5 million for investors, as well as innovative governance reforms regarding insider trading.
(more . . .)

SRKW spearheads consumer protection class actions in Michigan and New Jersey against General Motors and Mercedes Benz (more . . .)

SRKW attorneys win victory at trial against two major drug companies
SRKW was part of the trial team that won a major victory against the drug companies AstraZeneca and Bristol Myers Squibb relating to their unlawful inflation of the Average Wholesale Price for several drugs.
(more . . .)

SRKW Obtains $120 Million in Settlements from OSB Manufacturers
SRKW is working to obtain final court approval of $120 million in settlements of a major antirust case against nine manufacturers of Oriented Strand Board (OSB), a wood-based building material used in most residential construction. SRKW developed and prosecuted this case against the major manufacturers of OSB, who conspired to fix, raise, maintain and stabilize the prices at which OSB was sold in the U.S. (more . . .)

SRKW Obtains $350 Million Recovery for Consumers in Prescription Drug Case Involving McKesson
In a key drug overcharge case, SRKW has obtained a $350 million settlement of all claims on behalf of a nationwide class of consumers and third-party payors against McKesson Corp.
(more . . .)

SRKW represents ERISA plan participants to bring important changes to the plan (more . . .)